3 results
Approved WMOCompleted
To provide access to Radium-223 dichloride to patients diagnosed with CRPC/HRPC with bonemetastasis.
Approved WMOPending
To study the impact on intra-arterial ATP infusion on Annexin A5 targeting.
Approved WMOCompleted
The objective of this study is to assess efficacy and safety of radium 223 dichloride in combination with exemestane and everolimus in subjects with human epidermal growth factor receptor 2 (HER2) negative, hormone receptor positive breast cancer…